A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
Public ClinicalTrials.gov record NCT02815280. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind Study to Compare the Efficacy, Safety and Long-Term Safety of Topical Administration of FMX-101 for 1 Year in the Treatment of Moderate-to-Severe Acne Vulgaris, Study FX2014-05
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 3 study to evaluate the efficacy, safety and long-term safety of the topical administration of FMX-101, 4% minocycline foam for the treatment of moderate-to-severe acne vulgaris.
Study identification
- NCT ID
- NCT02815280
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 495 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 9 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2016
- Primary completion
- Oct 12, 2017
- Completion
- Oct 12, 2017
- Last update posted
- Jan 17, 2022
2016 – 2017
United States locations
- U.S. sites
- 35
- U.S. states
- 22
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Glendale | Arizona | 85308 | — |
| Not listed | Rogers | Arkansas | 72758 | — |
| Not listed | Oceanside | California | 92049 | — |
| Not listed | Denver | Colorado | 80220 | — |
| Not listed | Hialeah | Florida | 33016 | — |
| Not listed | Miami | Florida | 33126 | — |
| Not listed | Miami | Florida | 33175 | — |
| Not listed | Sweetwater | Florida | 33172 | — |
| Not listed | Marietta | Georgia | 30060 | — |
| Not listed | Snellville | Georgia | 30078 | — |
| Not listed | Chicago | Illinois | 60611 | — |
| Not listed | Carmel | Indiana | 46032 | — |
| Not listed | Indianapolis | Indiana | 46256 | — |
| Not listed | Overland Park | Kansas | 66215 | — |
| Not listed | Owensboro | Kentucky | 42303 | — |
| Not listed | Crowley | Louisiana | 70526 | — |
| Not listed | Clarkston | Michigan | 48346 | — |
| Not listed | Detroit | Michigan | 48202 | — |
| Not listed | Montclair | New Jersey | 07042 | — |
| Not listed | Verona | New Jersey | 07044 | — |
| Not listed | Albuquerque | New Mexico | 87106 | — |
| Not listed | New York | New York | 10022 | — |
| Not listed | The Bronx | New York | 10458 | — |
| Not listed | Raleigh | North Carolina | 27612 | — |
| Not listed | Cleveland | Ohio | 44121 | — |
| Not listed | Hazleton | Pennsylvania | 18201 | — |
| Not listed | Chattanooga | Tennessee | 37421 | — |
| Not listed | Goodlettsville | Tennessee | 37072 | — |
| Not listed | Austin | Texas | 78746 | — |
| Not listed | New Braunfels | Texas | 78130 | — |
| Not listed | Port Arthur | Texas | 77640 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | Sugar Land | Texas | 77479 | — |
| Not listed | Salt Lake City | Utah | 84117 | — |
| Not listed | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02815280, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 17, 2022 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02815280 live on ClinicalTrials.gov.